HCL Technologies is projected to report 4.3%-6.8% YoY revenue growth for Q3FY25. Brokerages foresee varying outcomes for revenue and profit, with key focus on software business, margin guidance, and deal activity.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.